High-Dose Interleukin-2 Followed by Temozolomide Results in Response Rates of High Quality in Metastatic Melanoma

被引：0
|
作者：
Fateh, Salman [1 ]
Schell, Todd
Gingrich, Rebecca [1 ]
Neves, Rogerio [2 ]
Drabick, Joseph [1 ]
机构：
[1] Penn State Hershey Med Ctr, Dept Hematol & Oncol, Hershey, PA USA
[2] Penn State Hershey Med Ctr, Dept Plast Surg, Hershey, PA USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2009年 / 32卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：956 / 956
页数：1
相关论文
共 50 条
  • [41] Thrombotic thrombocytopenic ourpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanoma
    Alexandrescu, DT
    Maddukuri, P
    Wiernik, PH
    Dutcher, JP
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (02) : 144 - 147
  • [42] Syndrome of Inappropriate Antidiuretic Hormone Secretion Caused by High-Dose Bolus Interleukin-2 Therapy for Metastatic Melanoma
    Green, Myke R.
    Woolery, Joseph E.
    Elquza, Emad
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (05) : E159 - E161
  • [43] High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: Long-term survival update
    Atkins, MB
    Kunkel, L
    Sznol, M
    Rosenberg, SA
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 2000, 6 : S11 - S14
  • [44] A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma
    Monk, Paul
    Lam, Elaine
    Mortazavi, Amir
    Kendra, Kari
    Lesinski, Gregory B.
    Mace, Thomas A.
    Geyer, Susan
    Carson, William E., III
    Tahiri, Sanaa
    Bhinder, Arvinder
    Clinton, Steven K.
    Olencki, Thomas
    JOURNAL OF IMMUNOTHERAPY, 2014, 37 (03) : 180 - 186
  • [45] Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
    Ajjai Alva
    Gregory A. Daniels
    Michael K. K. Wong
    Howard L. Kaufman
    Michael A. Morse
    David F. McDermott
    Joseph I. Clark
    Sanjiv S. Agarwala
    Gerald Miletello
    Theodore F. Logan
    Ralph J. Hauke
    Brendan Curti
    John M. Kirkwood
    Rene Gonzalez
    Asim Amin
    Mayer Fishman
    Neeraj Agarwal
    James N. Lowder
    Hong Hua
    Sandra Aung
    Janice P. Dutcher
    Cancer Immunology, Immunotherapy, 2016, 65 : 1533 - 1544
  • [46] Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
    Alva, Ajjai
    Daniels, Gregory A.
    Wong, Michael K. K.
    Kaufman, Howard L.
    Morse, Michael A.
    McDermott, David F.
    Clark, Joseph I.
    Agarwala, Sanjiv S.
    Miletello, Gerald
    Logan, Theodore F.
    Hauke, Ralph J.
    Curti, Brendan
    Kirkwood, John M.
    Gonzalez, Rene
    Amin, Asim
    Fishman, Mayer
    Agarwal, Neeraj
    Lowder, James N.
    Hua, Hong
    Aung, Sandra
    Dutcher, Janice P.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (12) : 1533 - 1544
  • [47] Activity of high-dose continuous infusion plus pulse Interleukin-2 and famotidine in metastatic kidney cancer or melanoma previously-treated with Interleukin-2
    Quan, WDY
    Ramirez, M
    Elsamaloty, HM
    Tyre, CC
    Quan, FM
    Ghai, V
    Merrick, HW
    Walker, PR
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 624 - 625
  • [48] Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin-2
    Spanknebel, K
    Hurst-Wicker, K
    Cheung, YK
    Hesdorffer, C
    DeRaffele, G
    Kaufman, H
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S77 - S77
  • [49] Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin-2
    K. Spanknebel
    K. Hurst-Wicker
    Y. K. Cheung
    C. Hesdorffer
    G. DeRaffele
    H. Kaufman
    Annals of Surgical Oncology, 2004, 11 : S77 - S77
  • [50] High dose systemic interleukin-2 for metastatic melanoma in patients with treated brain metastases
    Lochhead, R
    McKhann, G
    Hankinson, T
    Isaacson, S
    Hesdorffer, C
    DeRaffele, G
    Sisti, J
    Bruce, J
    Kaufman, H
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S15 - S15
12345